Skip to main content

Advertisement

Log in

Use of unnecessary medications by patients with advanced cancer: cross-sectional survey

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Cancer patients at the end of life take numerous medications. However, it has not been assessed what proportion of patients take unnecessary medications and which patients are at risk for doing so.

Methods

Cross-sectional survey of medications utilized by terminally ill ambulatory cancer patients, with the aim of identifying medications considered unnecessary as per explicit criteria. The criteria took into account whether drugs could benefit patients with terminal cancer.

Results

Among 87 patients, 21 (24%, 95% confidence interval [CI] 15.6–34.5%) were taking at least one unnecessary medication, the most common being gastric protectors. In multivariable analyses, patients with Charlson Comobidity Index ≤ 1 (OR: 4.49, CI95% 1.32–15.26; p = 0.01) or whose medication list had not been reconciled by physicians (OR: 6.38, CI95% 1.21–33.40; p = 0.02) were more likely to use an unnecessary medication.

Conclusion

Patients with advanced cancer take many medications considered unnecessary. Medication reconciliation should be performed routinely for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Halevy A, Brody BA (1999) Medical futility in end-of-life care. JAMA 282(14):1331–1332

    Article  PubMed  CAS  Google Scholar 

  2. Honegger HP (1991) Avoiding futility: assessment of cancer patients in intensive care units. Ann Oncol 2(8):530–531

    PubMed  CAS  Google Scholar 

  3. von Gruenigen VE, Daly BJ (2005) Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 97(2):638–644

    Article  Google Scholar 

  4. Jecker NS, Pearlman RA (1992) Medical futility. Who decides? Arch Intern Med 152(6):1140–1144

    Article  PubMed  CAS  Google Scholar 

  5. Burt RA (2002) The medical futility debate: patient choice, physician obligation, and end-of-life care. J Palliat Med 5(2):249–254

    Article  PubMed  Google Scholar 

  6. Cantor MD, Braddock CH 3rd, Derse AR et al (2003) Do-not-resuscitate orders and medical futility. Arch Intern Med 163(22):2689–2694

    Article  PubMed  Google Scholar 

  7. Kasman DL (2004) When is medical treatment futile? A guide for students, residents, and physicians. J Gen Intern Med 19(10):1053–1056

    Article  PubMed  Google Scholar 

  8. Khatcheressian J, Harrington SB, Lyckholm LJ, Smith TJ (2008) 'Futile care': what to do when your patient insists on chemotherapy that likely won't help. Oncology (Williston Park) 22(8):881–888, discussion 893, 896, 898

    Google Scholar 

  9. Riechelmann RP, Krzyzanowska MK, Zimmermann C (2009) Futile medication use in terminally ill cancer patients. Support Care Cancer 17(6):745–748

    Article  PubMed  Google Scholar 

  10. Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15(12):1407–1412

    Article  PubMed  Google Scholar 

  11. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55(4):590–595

    Article  PubMed  Google Scholar 

  12. Riechelmann RP, Zimmermann C, Chin SN et al (2008) Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 35(5):535–543

    Article  PubMed  Google Scholar 

  13. Corcoran ME (1997) Polypharmacy in the older patient with cancer. Cancer Control 4(5):419–428

    PubMed  Google Scholar 

  14. Riechelmann RP, Del Giglio A (2009) Drug interactions in oncology: how common are they? Ann Oncol 20:1907–1912

    Article  PubMed  CAS  Google Scholar 

  15. Glare P, Virik K, Jones M et al (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327(7408):195–198

    Article  PubMed  Google Scholar 

  16. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655

    Article  PubMed  CAS  Google Scholar 

  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  PubMed  CAS  Google Scholar 

  18. Curtis EB, Walsh TD (1993) Prescribing practices of a palliative care service. J Pain Symptom Manage 8(5):312–316

    Article  PubMed  CAS  Google Scholar 

  19. Mercadante S, Fulfaro F, Casuccio A (2001) Pattern of drug use by advanced cancer patients followed at home. J Palliat Care 17(1):37–40

    PubMed  CAS  Google Scholar 

  20. Nauck F, Ostgathe C, Klaschik E et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18(2):100–107

    Article  PubMed  Google Scholar 

  21. Nicholson A, Andrew I, Etherington R, Gamlin R, Lovel T, Lloyd J. (2001) Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a palliative care unit. The International Journal of Pharmacy Practice (September issue):71

  22. Kite S, Wilkinson S (2002) Beyond futility: to what extent is the concept of futility useful in clinical decision-making about CPR? Lancet Oncol 3(10):638–642

    Article  PubMed  Google Scholar 

  23. Vollrath AM, Sinclair C, Hallenbeck J (2005) Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med 8(4):876–881

    Article  PubMed  Google Scholar 

  24. Samano ES, Ribeiro LM, Campos AS et al (2005) Use of complementary and alternative medicine by Brazilian oncologists. Eur J Cancer Care (Engl) 14(2):143–148

    Article  CAS  Google Scholar 

  25. Basu TK (1985) Drug–vitamin interaction. Int J Vitam Nutr Res Suppl 27:247–258

    PubMed  CAS  Google Scholar 

Download references

Conflict of interests

The authors state that there is no conflict of interest in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Miranda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fede, A., Miranda, M., Antonangelo, D. et al. Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer 19, 1313–1318 (2011). https://doi.org/10.1007/s00520-010-0947-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-010-0947-1

Keywords

Navigation